Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

(ROSG) logo

About (ROSG) Stock (NASDAQ:ROSG)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.44
50-Day Range
$0.43
$0.43
52-Week Range
$0.23
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

ROSG Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Rosetta Genomics Ltd ROSGQ
See More Headlines

ROSG Stock Analysis - Frequently Asked Questions

(ROSG) (NASDAQ:ROSG) released its quarterly earnings results on Thursday, May, 19th. The medical research company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.02. The medical research company had revenue of $2.60 million for the quarter, compared to analyst estimates of $3.36 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Cos (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), Eyepoint Pharmaceuticals (EYPT) and (SCMP) (SCMP).

Company Calendar

Last Earnings
5/19/2016
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
CIK
1362959
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ROSG) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners